Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Merrimack Pharmaceuticals

NASDAQ MACK
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

218.66M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
212.67M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.22
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
14.45M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
12.83 %

Upcoming events Merrimack Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Merrimack Pharmaceuticals

Stock analysis Merrimack Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-8.91 28.32
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
11.66 4.48
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-93.07 11.33
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
2.62 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-11.07 10.75

Price change Merrimack Pharmaceuticals per year

3.65$ 9.35$
Min Max

Summary analysis Merrimack Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Merrimack Pharmaceuticals

Revenue and net income Merrimack Pharmaceuticals

All parameters

Stock news Merrimack Pharmaceuticals

All news
14 February в 01:30

Merrimack Pharmaceuticals to Hold Meeting on Corporate Dissolution

14 February в 01:30

Merrimack Pharmaceuticals to Hold Meeting on Corporate Dissolution

14 February в 00:55

Merrimack Pharmaceuticals to Get $225M Milestone Payment After FDA's Supplemental NDA Approval

14 February в 00:55

Merrimack Pharmaceuticals to Get $225M Milestone Payment After FDA's Supplemental NDA Approval

9 November 2022 в 15:15

Merrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACK

9 November 2022 в 15:11

Merrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACK

About company Merrimack Pharmaceuticals

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Address:
One Broadway, Cambridge, MA, United States, 02142
Company name: Merrimack Pharmaceuticals
Issuer ticker: MACK
ISIN: US5903282094
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2012-03-29
Sector: Healthcare
Industry: Biotechnology
Site: https://www.merrimack.com

On which stock exchange are Merrimack Pharmaceuticals (MACK) stocks traded?

Merrimack Pharmaceuticals (MACK) stocks are traded on NASDAQ.

What is the ticker of Merrimack Pharmaceuticals stocks (MACK)?

The stock ticker of Merrimack Pharmaceuticals’s stocks or in other words, the code is MACK. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Merrimack Pharmaceuticals (MACK) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Merrimack Pharmaceuticals (MACK) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Merrimack Pharmaceuticals (MACK) stocks traded?

Merrimack Pharmaceuticals (MACK) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Merrimack Pharmaceuticals (MACK) stocks today?

The current price of Merrimack Pharmaceuticals stocks on 30.05.2024 is dollars. per share.

What is the dynamics of Merrimack Pharmaceuticals (MACK) stocks from the beginning of the year?

Merrimack Pharmaceuticals (MACK) quotes have increased by -100% from the beginning of the year up to dollars. per 1 stocks.

How much did Merrimack Pharmaceuticals (MACK) stocks increase in may 2024?

This month Merrimack Pharmaceuticals (MACK) quotes have increased by -100% to dollars. per share.

How much are Merrimack Pharmaceuticals (MACK) stocks worth?

Today, on October, 30.05.2024 Merrimack Pharmaceuticals’s (MACK) stocks cost dollars..

What is the market capitalization of Merrimack Pharmaceuticals (MACK)?

Capitalization is the market value of Merrimack Pharmaceuticals (MACK) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 30.05.2024, the market capitalization of Merrimack Pharmaceuticals (MACK) is estimated at about 218658760 dollars.